Asahi Kasei to Double Production Capacity for PIMEL™ Photosensitive Polyimide by 2030
Strengthening supply resilience of key material for the global semiconductor industry TOKYO–(BUSINESS WIRE)–Diversified global manufacturer Asahi Kasei... Read more.
Investor Group Acquires 220,000 SPAR Group Shares at 76% Premium
CHARLOTTE, N.C.–(BUSINESS WIRE)–SPAR Group, Inc. (NASDAQ: SGRP) (“SPAR”, “SPAR Group” or the “Company”), a provider of retail and brand services,... Read more.
Veracyte Completes NIGHTINGALE Clinical Utility Trial Enrollment for Percepta Nasal Swab Lung Cancer Test
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–$VCYT—Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced it has met... Read more.
Harmony Biosciences to Present Rare Epilepsy Data at the 36th International Epilepsy Congress
PLYMOUTH MEETING, Pa.–(BUSINESS WIRE)–Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today announced that it will present data from its rare epilepsy... Read more.
Fintech Startup Payment Labs Raises $3.25 Million Seed Round to Power Payments in Sports, Creator Economy, Esports, and More
Led By Aperture Venture Capital, Funding Will Scale Purpose-Built SaaS Platform that Brings Efficiency and Compliance to Complex Payment Processes LOS ANGELES–(BUSINESS... Read more.
Buzzacott Partners with MindBridge to Enhance Audit Processes with AI-Driven Analytics
Advanced financial decision intelligence will enhance audit workflows, allowing for more proactive risk management and improved audit quality OTTAWA, Ontario–(BUSINESS... Read more.
Charles River Joins EASYGEN Consortium, Supports Development of Bedside CAR-T Manufacturing
WILMINGTON, Mass.–(BUSINESS WIRE)–$CRL #LIFEatCRL–Charles River Laboratories International, Inc. (NYSE: CRL) has joined the EASYGEN (Easy Workflow... Read more.
Audacity IB Advises on the Sale of Silicon Valley-Based Owens Design to Automated Industrial Robotics Inc.
LOS ANGELES–(BUSINESS WIRE)–#advancedmanufacturing—Audacity IB, a nationally recognized boutique M&A investment bank and growth-to-exit consulting... Read more.
Alcon to Present at 2025 Baird Global Healthcare Conference
GENEVA–(BUSINESS WIRE)–Regulatory News: Alcon (SIX/NYSE: ALC) CEO David Endicott will present at the 2025 Baird Global Healthcare Conference on Tuesday,... Read more.
Genmab Receives FDA Breakthrough Therapy Designation for Rinatabart Sesutecan (Rina-S®) in Advanced Endometrial Cancer (EC)
Breakthrough Therapy Designation granted to Rina-S for the treatment of adult patients with recurrent or progressive endometrial cancer (EC) who have disease progression... Read more.